1. Home
  2. TLRY

as 10-08-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.

Founded: N/A Country:
Canada
Canada
Employees: N/A City: NEW YORK
Market Cap: 1.8B IPO Year: 2018
Target Price: $1.58 AVG Volume (30 days): 83.2M
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.46 EPS Growth: N/A
52 Week Low/High: $0.35 - $1.88 Next Earning Date: 10-09-2025
Revenue: $821,309,000 Revenue Growth: 4.10%
Revenue Growth (this year): 6.66% Revenue Growth (next year): 4.75%

Share on Social Networks: